These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 24312444)

  • 1. Macrophage specific caspase-1/11 deficiency protects against cholesterol crystallization and hepatic inflammation in hyperlipidemic mice.
    Hendrikx T; Bieghs V; Walenbergh SM; van Gorp PJ; Verheyen F; Jeurissen ML; Steinbusch MM; Vaes N; Binder CJ; Koek GH; Stienstra R; Netea MG; Hofker MH; Shiri-Sverdlov R
    PLoS One; 2013; 8(12):e78792. PubMed ID: 24312444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
    Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
    Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic overexpression of Cyp27a1 reduces hepatic inflammation independently of 27-hydroxycholesterol levels in Ldlr(-/-) mice.
    Hendrikx T; Jeurissen ML; Bieghs V; Walenbergh SM; van Gorp PJ; Verheyen F; Houben T; Guichot YD; Gijbels MJ; Leitersdorf E; Hofker MH; Lütjohann D; Shiri-Sverdlov R
    J Hepatol; 2015 Feb; 62(2):430-6. PubMed ID: 25281859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow-specific caspase-1/11 deficiency inhibits atherosclerosis development in Ldlr(-/-) mice.
    Hendrikx T; Jeurissen ML; van Gorp PJ; Gijbels MJ; Walenbergh SM; Houben T; van Gorp R; Pöttgens CC; Stienstra R; Netea MG; Hofker MH; Donners MM; Shiri-Sverdlov R
    FEBS J; 2015 Jun; 282(12):2327-38. PubMed ID: 25817537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.
    Wouters K; van Gorp PJ; Bieghs V; Gijbels MJ; Duimel H; Lütjohann D; Kerksiek A; van Kruchten R; Maeda N; Staels B; van Bilsen M; Shiri-Sverdlov R; Hofker MH
    Hepatology; 2008 Aug; 48(2):474-86. PubMed ID: 18666236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation.
    Tang Y; Cao G; Min X; Wang T; Sun S; Du X; Zhang W
    J Physiol Biochem; 2018 Nov; 74(4):503-510. PubMed ID: 30019185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiolipin inhibitor ameliorates the non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation.
    Liu J; Wang T; He K; Xu M; Gong JP
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8158-8167. PubMed ID: 31599445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid DLL4 Does Not Contribute to the Pathogenesis of Non-Alcoholic Steatohepatitis in Ldlr-/- Mice.
    Jeurissen ML; Walenbergh SM; Houben T; Hendrikx T; Li J; Oligschlaeger Y; van Gorp PJ; Gijbels MJ; Bitorina A; Nessel I; Radtke F; Vooijs M; Theys J; Shiri-Sverdlov R
    PLoS One; 2016; 11(11):e0167199. PubMed ID: 27898698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cholesterol derivative 27-hydroxycholesterol reduces steatohepatitis in mice.
    Bieghs V; Hendrikx T; van Gorp PJ; Verheyen F; Guichot YD; Walenbergh SM; Jeurissen ML; Gijbels M; Rensen SS; Bast A; Plat J; Kalhan SC; Koek GH; Leitersdorf E; Hofker MH; Lütjohann D; Shiri-Sverdlov R
    Gastroenterology; 2013 Jan; 144(1):167-178.e1. PubMed ID: 23041327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP3 Deletion Inhibits the Non-alcoholic Steatohepatitis Development and Inflammation in Kupffer Cells Induced by Palmitic Acid.
    Cai C; Zhu X; Li P; Li J; Gong J; Shen W; He K
    Inflammation; 2017 Dec; 40(6):1875-1883. PubMed ID: 28730512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells.
    Bieghs V; Verheyen F; van Gorp PJ; Hendrikx T; Wouters K; Lütjohann D; Gijbels MJ; Febbraio M; Binder CJ; Hofker MH; Shiri-Sverdlov R
    PLoS One; 2012; 7(3):e34378. PubMed ID: 22470565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice.
    Miura K; Yang L; van Rooijen N; Brenner DA; Ohnishi H; Seki E
    Hepatology; 2013 Feb; 57(2):577-89. PubMed ID: 22987396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release.
    Pan J; Ou Z; Cai C; Li P; Gong J; Ruan XZ; He K
    Cell Immunol; 2018 Oct; 332():111-120. PubMed ID: 30103942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice.
    Mridha AR; Wree A; Robertson AAB; Yeh MM; Johnson CD; Van Rooyen DM; Haczeyni F; Teoh NC; Savard C; Ioannou GN; Masters SL; Schroder K; Cooper MA; Feldstein AE; Farrell GC
    J Hepatol; 2017 May; 66(5):1037-1046. PubMed ID: 28167322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cells.
    Chen HW; Yen CC; Kuo LL; Lo CW; Huang CS; Chen CC; Lii CK
    Toxicol Appl Pharmacol; 2020 Apr; 393():114941. PubMed ID: 32126212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease.
    Bieghs V; Van Gorp PJ; Wouters K; Hendrikx T; Gijbels MJ; van Bilsen M; Bakker J; Binder CJ; Lütjohann D; Staels B; Hofker MH; Shiri-Sverdlov R
    PLoS One; 2012; 7(1):e30668. PubMed ID: 22295101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells.
    Csak T; Ganz M; Pespisa J; Kodys K; Dolganiuc A; Szabo G
    Hepatology; 2011 Jul; 54(1):133-44. PubMed ID: 21488066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of NLRP3 inflammasome by thioredoxin-interacting protein in mouse Kupffer cells as a regulatory mechanism for non-alcoholic fatty liver disease development.
    He K; Zhu X; Liu Y; Miao C; Wang T; Li P; Zhao L; Chen Y; Gong J; Cai C; Li J; Li S; Ruan XZ; Gong J
    Oncotarget; 2017 Jun; 8(23):37657-37672. PubMed ID: 28499273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1α and IL-1β-producing macrophages populate lung tumor lesions in mice.
    Terlizzi M; Colarusso C; Popolo A; Pinto A; Sorrentino R
    Oncotarget; 2016 Sep; 7(36):58181-58192. PubMed ID: 27528423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRP3 inflammasome mediates interleukin-1β production in immune cells in response to Acinetobacter baumannii and contributes to pulmonary inflammation in mice.
    Kang MJ; Jo SG; Kim DJ; Park JH
    Immunology; 2017 Apr; 150(4):495-505. PubMed ID: 28032341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.